Replies to post #188413 on Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

"If he didn't expect success, he wouldn't be talking about commercialization and wouldn't waste good money on stockpiling a supply for it. IMO of course."

Not necessarily true. As anybody in the drug development business knows, you don't know what the data looks like until you actually have the data and it's analyzed. Missling is smart to stockpile A2-73 because if the trials are successful, he doesn't want there to be a delay while sufficient quantities are made.

And if the data are bad, the whole thing goes down the drain anyway.

[XenaLives]

So does this imply that the consortium will be running a trial and that multiple drugs, 2-73 included, will be used?

He said he thinks that 2-73 would work on Schizophrenia but we don't have money for all these trials so we're piggy backing on ERP to be involved but not invest in a trial.

[kevindenver]

For those who actually know about AVXL and it's CEO, I'm sure some would agree, this is a very different sounding Dr. Missing versus presentations of the past.

I think I like it.